229 related articles for article (PubMed ID: 33092075)
1. Four and a Half LIM Domains 2 (FHL2) Contribute to the Epithelial Ovarian Cancer Carcinogenesis.
Wang C; Lv X; He C; Davis JS; Wang C; Hua G
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092075
[TBL] [Abstract][Full Text] [Related]
2. The four and a half LIM domains 2 (FHL2) regulates ovarian granulosa cell tumor progression via controlling AKT1 transcription.
Hua G; He C; Lv X; Fan L; Wang C; Remmenga SW; Rodabaugh KJ; Yang L; Lele SM; Yang P; Karpf AR; Davis JS; Wang C
Cell Death Dis; 2016 Jul; 7(7):e2297. PubMed ID: 27415427
[TBL] [Abstract][Full Text] [Related]
3. miR-340-FHL2 axis inhibits cell growth and metastasis in ovarian cancer.
Huang Z; Li Q; Luo K; Zhang Q; Geng J; Zhou X; Xu Y; Qian M; Zhang JA; Ji L; Wu J
Cell Death Dis; 2019 May; 10(5):372. PubMed ID: 31068580
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of FHL2 promotes tumorigenesis in cervical cancer and is correlated with poor prognosis.
Jin X; Jiao X; Jiao J; Zhang T; Cui B
Gene; 2018 Aug; 669():99-106. PubMed ID: 29800735
[TBL] [Abstract][Full Text] [Related]
5. Four and a half LIM domains 2 contributes to the development of human tongue squamous cell carcinoma.
Wang Q; Wang X; Tian X; Tang R; Xu X
J Mol Histol; 2016 Apr; 47(2):105-16. PubMed ID: 26759260
[TBL] [Abstract][Full Text] [Related]
6. High level of FHL2 exacerbates the outcome of non-small cell lung cancer (NSCLC) patients and the malignant phenotype in NSCLC cells.
Li N; Xu L; Zhang J; Liu Y
Int J Exp Pathol; 2022 Jun; 103(3):90-101. PubMed ID: 35366027
[TBL] [Abstract][Full Text] [Related]
7. The LIM domain protein FHL2 interacts with the NR5A family of nuclear receptors and CREB to activate the inhibin-α subunit gene in ovarian granulosa cells.
Matulis CK; Mayo KE
Mol Endocrinol; 2012 Aug; 26(8):1278-90. PubMed ID: 22734036
[TBL] [Abstract][Full Text] [Related]
8. KLF8 promotes tumorigenesis, invasion and metastasis of colorectal cancer cells by transcriptional activation of FHL2.
Yan Q; Zhang W; Wu Y; Wu M; Zhang M; Shi X; Zhao J; Nan Q; Chen Y; Wang L; Cheng T; Li J; Bai Y; Liu S; Wang J
Oncotarget; 2015 Sep; 6(28):25402-17. PubMed ID: 26320172
[TBL] [Abstract][Full Text] [Related]
9. The roles of FHL2 in cancer.
Zhang J; Zeng Q; She M
Clin Exp Med; 2023 Nov; 23(7):3113-3124. PubMed ID: 37103649
[TBL] [Abstract][Full Text] [Related]
10. Expression, location and biological effects of four and a half LIM domain protein 2 (FHL2) on granulosa cells in ovine.
Zhang L; Li R; Chen L; Xing Z; Song Y; Nie X; Wang L; Han H; Liu A; Ma X; Ma RZ; Tian S
Reprod Domest Anim; 2020 Jun; 55(6):737-746. PubMed ID: 32181932
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of four-and-a-half LIM domain protein-2 increases survival, migratory capacity, and paracrine function of human early outgrowth cells through activation of the sphingosine kinase-1 pathway: implications for endothelial regeneration.
Ebrahimian T; Arfa O; Simeone S; Lemarié CA; Lehoux S; Wassmann S
Circ Res; 2014 Jan; 114(1):114-23. PubMed ID: 24084691
[TBL] [Abstract][Full Text] [Related]
12. FHL2 deficiency impairs follicular development and fertility by attenuating EGF/EGFR/YAP signaling in ovarian granulosa cells.
Wang C; Sun H; Davis JS; Wang X; Huo L; Sun N; Huang Q; Lv X; Wang C; He C; He C; Zhou Y; Wu J; Yang L; Hua G
Cell Death Dis; 2023 Apr; 14(4):239. PubMed ID: 37015904
[TBL] [Abstract][Full Text] [Related]
13. FHL2 promotes the aggressiveness of lung adenocarcinoma by inhibiting autophagy via activation of the PI3K/AKT/mTOR pathway.
Wang S; Liu B; Su Y; Wang N; Dong P; Xu X; Huang L; Li S; Gu J; Qiu Y; Deng J; Lin Z; Zhou Y
Thorac Cancer; 2024 Mar; 15(8):630-641. PubMed ID: 38323374
[TBL] [Abstract][Full Text] [Related]
14. Silencing of the long noncoding RNA LINC01132 alleviates the oncogenicity of epithelial ovarian cancer by regulating the microRNA‑431‑5p/SOX9 axis.
Zhu W; Xiao X; Chen J
Int J Mol Med; 2021 Aug; 48(2):. PubMed ID: 34132375
[TBL] [Abstract][Full Text] [Related]
15. FHL2 promotes tubular epithelial-to-mesenchymal transition through modulating β-catenin signalling.
Cai T; Sun D; Duan Y; Qiu Y; Dai C; Yang J; He W
J Cell Mol Med; 2018 Mar; 22(3):1684-1695. PubMed ID: 29193729
[TBL] [Abstract][Full Text] [Related]
16. Targeting HSF1 leads to an antitumor effect in human epithelial ovarian cancer.
Chen YF; Wang SY; Yang YH; Zheng J; Liu T; Wang L
Int J Mol Med; 2017 Jun; 39(6):1564-1570. PubMed ID: 28487934
[TBL] [Abstract][Full Text] [Related]
17. Focal adhesion kinase interacts with the transcriptional coactivator FHL2 and both are overexpressed in epithelial ovarian cancer.
Gabriel B; Mildenberger S; Weisser CW; Metzger E; Gitsch G; Schüle R; Müller JM
Anticancer Res; 2004; 24(2B):921-7. PubMed ID: 15161045
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo.
Zeng S; Liu S; Feng J; Gao J; Xue F
Cancer Biomark; 2019; 24(4):421-428. PubMed ID: 30909184
[TBL] [Abstract][Full Text] [Related]
19. Transcription factor ZIC2 regulates the tumorigenic phenotypes associated with both bulk and cancer stem cells in epithelial ovarian cancer.
Chen H; Lee LJ; Vincent KM; Xu Z; Liu J; Zhang G; Nakevska Z; Smith D; Lee CH; Postovit LM; Fu Y
Oncogene; 2024 May; 43(22):1688-1700. PubMed ID: 38594503
[TBL] [Abstract][Full Text] [Related]
20. Circ-PGAM1 promotes malignant progression of epithelial ovarian cancer through regulation of the miR-542-3p/CDC5L/PEAK1 pathway.
Zhang C; Li Y; Zhao W; Liu G; Yang Q
Cancer Med; 2020 May; 9(10):3500-3521. PubMed ID: 32167655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]